Clinical Trial 39158

share

Brownsburg, IN 46112


Study Summary:

Phase 2/3, 24 week, study comparing the efficcy and safety of PT001 to placebo and open-label Spiriva Respimat in subjects with persistent Asthma. 


Qualified Participants Must:

• Have persistent Asthma
• Be 12-80 years old
• Have no other lung or breathing issues, not smoked in the last 6 months


Qualified Participants May Receive:

Study medication for Ashtma, study supplies, study exams and compensation for time and travel.


Study is Available At:

Investigators Research Group
321 E. Northfield Drive
Suite 100
Brownsburg, IN 46112
View Clinic Location

 


If you or someone you care for is interested in participating in this clinical trial and lives within 50 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.